Effectiveness and long-term safety of prolonged gosereline and tibolone in women with endometriosis

Use of gonadotropin-releasing hormone agonists in patients with Hodgkin’s disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy

“…It is accepted that the loss of bone mineral density in this situation may be reduced significantly by using low doses of hormone replacement therapy (24) or tibolone (25). Thus, if a GnRH-a is considered the treatment of choice, then hormone replacement therapy should be used in combination.…”